Related Experiment Video

Updated: May 27, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

[Elements of metabolic control in children with type 1 diabetes before and after introduction to insulin analogues]

Liiljana Baloš, Silvija Sajić, Vera Zdravković

    Srpski Arhiv Za Celokupno Lekarstvo
    |November 11, 2011
    PubMed

    Insights

    Switching to insulin analogues in children with type 1 diabetes improves metabolic control and significantly reduces severe hypoglycemia and ketoacidosis. This treatment offers better disease management for pediatric patients.

    Area of Science:

    • Pediatric Endocrinology
    • Metabolic Disorders
    • Diabetes Management

    Background:

    • Type 1 diabetes (T1DM) in children presents a challenging, unstable disease course.
    • Insulin analogue therapy is increasingly recognized for its potential to enhance T1DM control.

    Purpose of the Study:

    • To evaluate metabolic control in pediatric T1DM patients after transitioning from human insulin to insulin analogues.
    • To assess the impact of insulin analogue treatment on glycemic control and acute complications.

    Main Methods:

    • A cohort of 59 children and adolescents (ages 2-19) with T1DM was studied.
    • Patients were switched from human insulin to insulin analogues, with data collected from medical records and patient/parent interviews.
    • Metabolic control and complication rates were assessed before and 6 months after the treatment switch.

    Main Results:

    • Glycolized hemoglobin (HbA1c) levels showed a trend towards decrease (9.27% to 8.63%) after 6 months of insulin analogue use (p=0.06).
    • Severe hypoglycemia incidence dropped significantly from 66.1% to 3.4% (p<0.001).
    • Ketoacidosis episodes decreased from 27.1% to 0% (p<0.001) within the same timeframe.

    Conclusions:

    • Insulin analogue therapy in children with T1DM provides effective metabolic control.
    • This treatment substantially lowers the risk of severe hypoglycemia and ketoacidosis in pediatric patients.
    Abstract

    More Related Videos

    Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet &#946; Cell Death10:34

    Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death

    Published on: December 21, 2016

    Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain08:32

    Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

    Published on: January 4, 2018

    Related Concept Videos

    Insulin: Dosing Regimen and Adverse Effects01:16

    Insulin: Dosing Regimen and Adverse Effects

    Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
    The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
    Hypoglycemia01:26

    Hypoglycemia

    Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
    Diabetes Mellitus: Overview and Type I Subtype01:22

    Diabetes Mellitus: Overview and Type I Subtype

    Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
    Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
    Type I Diabetes I: Introduction01:12

    Type I Diabetes I: Introduction

    Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
    Diabetes: Management and Pharmacotherapy01:15

    Diabetes: Management and Pharmacotherapy

    The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
    Insulin remains the cornerstone of treatment for most patients with type 1 and many...
    Diabetes Mellitus: Type 2 and Gestational01:22

    Diabetes Mellitus: Type 2 and Gestational

    Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...